The Oregon Health Authority has announced its proposed permanent rules governing serving and package limits for edibles and other non-flower products.
Despite consistent, near-unanimous feedback on the draft rules from the Oregon Cannabis Association and others in the cannabis business community, the OHA has not moved from its original low-potency limits of 5mg of THC per serving and 50mg per package for adult use, and and 100mg package limits for the medical market. These limits, as our members and others have testified, are unnecessarily low and will have unintended consequences for public health and the regulated market.
If you share our concerns about the OHA’s decision to allow only low-potency cannabis products to be sold in the regulated market, please take a moment to send a concise, direct and polite e-mail to the agency at firstname.lastname@example.org
Ask the agency to reconsider its rules. Please share with them a brief personal story about why this matters to you.
We also recommend addressing the following points:
- Low potency 5/50 serving and package limits are unnecessary to protect public health and public safety. In fact, they may increase risk because the limits are so low that
- Adult use customers who prefer moderate or higher potency cannabis products will simply buy more packages, increasing the risk of any given package falling into the wrong hands
- The extra production costs involved in supplying low potency products will be passed onto the consumer, raising costs and making legal and regulated products less competitive with illegal and unregulated products
- The unregulated illegal market will continue to supply unsafe products to customers who prefer a higher potency
- The adult use limits are drastically lower than Washington’s current limits and the expected limits in California (10/100). Oregon’s rules should be consistent with neighboring states both for ease of enforcement and to deter the illegal transfer of products across state lines
- The best defense against accidental ingestion of cannabis products is public education and appropriate labeling
While the OHA's decision is close to being made, there may still be time to change their minds. The Oregon Cannabis Association will continue our advocacy on this issue that impacts Oregon patients, consumers and businesses.